Analyst Ratings for Inovio Pharmaceuticals (INO) [Neutrals]
INO Rating Summary
INO Price Target Summary
- Highest: $4.00 (Oppenheimer)
- Lowest: $0.40 (Jefferies)
- Average: $1.80
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$1.80 (-82.4%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 48%
Avg. $ Target:
$1.80 (-82.4%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/9/2022 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
2.14 (10.20) |
376.64% | Details |
| 12/29/2021 | Jefferies » Updated 11/10/2023 |
Roger Song | New Coverage | Hold (N/A) |
0.40 (0.50) |
5.72 (10.20) |
78.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
